📰 Peripheral Nerve News
Page 2 - Peripheral Nerve News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Peripheral Nerve. Real-time updates on events, politics, business and more.
August 10, 2023
Regulatory progress for govorestat for the treatment of Classic Galactosemia, with potential NDA submission based on discussions with the FDA as well as EMA Marketing Authorization Application... -Today at 07:04 am- MarketScreener
June 29, 2023
One day last fall, Sean Wraith suffered a serious knee injury in a high school football game in northern California. Subsequent surgery was not able to repair the damage to
June 26, 2023
The Bellagroup CEO tells EW he is putting responsible hospitality and sustainability and solar power at the centre of their forward thinking.
June 21, 2023
Dublin, June 21, 2023 (GLOBE NEWSWIRE) -- The "Nerve Repair and Regeneration Devices: Global Strategic Business Report" report has been added to ...
June 20, 2023
/PRNewswire/ -- The "Nerve Repair and Regeneration Devices: Global Strategic Business Report" report has been added to ResearchAndMarkets.coms offering. The...
May 5, 2023
St. John’s Riverside Hospital with the St. John’s Medical Group in Yonkers held a ribbon-cutting ceremony on April 27 to mark the opening of its new Interventional Spine and Pain Management Center at 1022 N. Broadway in the Boyce Thompson Center. Ron Corti, president and CEO of the hospital, said, “The best part of my job is when a vision comes […]
May 3, 2023
/PRNewswire/ -- Prominently featured in The Inner Circle, Joey Kevin Grochmal is acknowledged as a Top Pinnacle Professional for his contributions as a...
August 11, 2022
Montclair, NJ (PRWEB) August 11, 2022 -- The statistics are alarming: At least a fifth of the US population has chronic pain.[1] Costs to society, ranging
July 14, 2022
Carlsbad, Calif. (PRWEB) July 14, 2022 -- Nalu Medical, Inc. (“Nalu”), a private company focused on innovative and minimally invasive solutions for chronic
May 12, 2022
12.05.2022 - Continued progress in three Phase 3 trials in areas of high unmet medical need, with multiple clinical milestones expected in 2022NEW YORK, May 12, 2022 (GLOBE NEWSWIRE) - Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage ...